伤口世界
  • 首页
  • 病情图文
    • 糖尿病足
    • 压疮
    • 感染伤口
    • 造口
    • 溃疡
      • 动脉性溃疡
      • 静脉性溃疡
      • 放射性溃疡
    • 烧伤
    • 创伤
    • 少见伤口
    • 祛疤止痒
    • 皮肤病
  • 医师讲座
  • 名医介绍
    专业服务
    • 糖尿病足
    • 压疮
    • 造口
    • 溃疡
    • 烧伤
    蔡道章院长

    Custom Mod Mega1

    主任医师、教授、博导,南方医科大学第三附属医院(广东省骨科医院)院长

    • 中德骨科伤口管理学校校长
    • 广东省骨科研究院运动医学研究所所长
    • 广东省内运动医学专业唯一的博士研究生导师
    • 美国哈弗大学医学院骨科访问学者
    • 专业特长处于省内领先、国内或国际先进水平以上
    • 2018年获得“国之名医卓越建树”荣誉称号
    • 2017年被评为全国卫生计生系统先进工作者、广东省医学领军人才
    • 中国医师协会运动医师分会副会长
    • STCOT中国部运动医学分会副主任委员
    • 广东省医学会关节外科分会主任委员
    • 广东省医学会运动医学会分会名誉主任委员
    • 独立承担过国家“863”课题,主持过10余项省、部级科研项目
    • 多份专业杂志编委
  • 文献精选
    伤口分类
    • 糖尿病足
    • 压疮
    • 感染伤口
    • 造口
    • 溃疡
    • 烧伤
    • 更多关于伤口信息
    最新文献
    • Periprocedural Use of Hypochlorous Acid Mist for Improving Healing and Cosmesis of the Face After Laser 2026-06-22 00:00

      Marianna Blyumin-Karasik1 | Jessica Colon2 | Sophie Gaer1 | Isabella Vigil1 | Sylvie Nguyen2 | Jordan Rosen1

      1 Precision Skin & Body Institute, Davie, Florida, USA | 2Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Davie, Florida, USA

      Correspondence: Marianna Blyumin-Karasik (该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。)

      Received: 12 May 2025 | Revised: 7 August 2025 | Accepted: 12 August 2025

      Funding: The authors received no specific funding for this work.

      Keywords: aesthetic | cosmeceuticals | hypochlorous acid | integrated skincare | laser treatment | photoaging | resurfacing laser

    • Phenylketonuria and type 1 diabetes: a clinical and nutritional challenge in a young adult—a case report 2026-06-21 00:00

      Carmine Piccolo1  · Sara de Candia1  · Annalisa Natalicchio1  · Sergio Di Molfetta1  · Irene Caruso1  · Luigi Laviola1  · Francesco Giorgino1  · Gian Pio Sorice

      Received: 16 December 2025 / Accepted: 11 March 2026 © The Author(s) 2026

      Abstract

      Aims Phenylketonuria and type 1 diabetes are lifelong metabolic disorders requiring complex and potentially conflicting nutritional strategies. Their coexistence is rare, yet management may become particularly challenging during transition from pediatric to adult care. We describe the case of a young adult with phenylketonuria who developed type 1 diabetes.

      Methods A 27-year-old man with longstanding phenylketonuria was referred to an adult metabolic-diabetes center after the diagnosis of type 1 diabetes. Clinical, biochemical, nutritional, and continuous glucose monitoring data were reviewed. The intervention included structured therapeutic education, transition from fixed insulin doses to a dynamic regimen based on carbohydrate counting, and revision of medical nutrition therapy using phenylketonuria-adapted low-protein foods and sugar-free phenylalanine-free amino acid supplements.

      Results At diagnosis, HbA1c was 11.5%, with markedly reduced C-peptide levels and high titer anti-GAD antibodies. Ini-tial diabetes management was associated with poor adherence to the phenylketonuria diet, increased intake of conventional protein sources, and elevated phenylalanine levels. After individualized insulin titration and nutritional intervention, HbA1c improved from 11.5% to 7.8%, phenylalanine levels decreased from 842 to 705 μmol/L, insulin requirement declined from 0.55 to 0.3 IU/kg/day, and continuous glucose monitoring showed improved glycemic control without increased hypoglyce-mia. The Glycemia Risk Index improved from high-risk Zone E to low-intermediate-risk Zone B.

      Conclusions This case highlights the need for personalized multidisciplinary care integrating continuous glucose monitor-ing, carbohydrate counting, and phenylketonuria specific nutrition to optimize both metabolic conditions.

      Keywords Phenylketonuria · Type 1 diabetes · CGM · multidisciplinary approach

  • 互动快递
  • 首页
  • 病情图文
    • 糖尿病足
    • 压疮
    • 感染伤口
    • 造口
    • 溃疡
      • 动脉性溃疡
      • 静脉性溃疡
      • 放射性溃疡
    • 烧伤
    • 创伤
    • 少见伤口
    • 祛疤止痒
    • 皮肤病
  • 医师讲座
  • 名医介绍
    • 专业服务
      • 糖尿病足
      • 压疮
      • 造口
      • 溃疡
      • 烧伤
    • 蔡道章院长
  • 文献精选
    • 伤口分类
      • 糖尿病足
      • 压疮
      • 感染伤口
      • 造口
      • 溃疡
      • 烧伤
      • 更多关于伤口信息
    • 最新文献
  • 互动快递
  • 当前位置: 
  • 首页
  • 文献精选

文献精选

Protective effect of Saussurea involucrata polysaccharide against skin dryness induced by ultraviolet radiation

Protective effect of Saussurea involucrata polysaccharide against skin dryness induced by ultraviolet radiation

伤口世界,
2025-10-13 00:00
发布于 文献精选
1021 Views
0 Comment

Traditional Asian Herbs in Skin Whitening: The Current Development and Limitations

Traditional Asian Herbs in Skin Whitening: The Current Development and Limitations

伤口世界,
2025-10-11 00:00
发布于 文献精选
1008 Views
0 Comment

Mitigating Glycation and Oxidative Stress in  Aesthetic Medicine: Hyaluronic Acid and  Trehalose Synergy for Anti-AGEs Action in Skin  Aging Treatment

Mitigating Glycation and Oxidative Stress in Aesthetic Medicine: Hyaluronic Acid and Trehalose Synergy for Anti-AGEs Action in Skin Aging Treatment

伤口世界,
2025-10-10 00:00
发布于 文献精选
1034 Views
0 Comment

Ginkgetin Alleviates Inflammation and Senescence by Targeting STING

Ginkgetin Alleviates Inflammation and Senescence by Targeting STING

伤口世界,
2025-10-09 00:00
发布于 文献精选
1032 Views
0 Comment

  • 首页
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 末页
第41页 共483页

Categories

  • 病情图文
  • 文献精选
  • 名医介绍
  • K2 Content
  • Periprocedural Use of Hypochlorous Acid Mist for Improving Healing and Cosmesis of the Face After Laser 2026-06-22 00:00

    Marianna Blyumin-Karasik1 | Jessica Colon2 | Sophie Gaer1 | Isabella Vigil1 | Sylvie Nguyen2 | Jordan Rosen1

    1 Precision Skin & Body Institute, Davie, Florida, USA | 2Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Davie, Florida, USA

    Correspondence: Marianna Blyumin-Karasik (该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。)

    Received: 12 May 2025 | Revised: 7 August 2025 | Accepted: 12 August 2025

    Funding: The authors received no specific funding for this work.

    Keywords: aesthetic | cosmeceuticals | hypochlorous acid | integrated skincare | laser treatment | photoaging | resurfacing laser

  • Phenylketonuria and type 1 diabetes: a clinical and nutritional challenge in a young adult—a case report 2026-06-21 00:00

    Carmine Piccolo1  · Sara de Candia1  · Annalisa Natalicchio1  · Sergio Di Molfetta1  · Irene Caruso1  · Luigi Laviola1  · Francesco Giorgino1  · Gian Pio Sorice

    Received: 16 December 2025 / Accepted: 11 March 2026 © The Author(s) 2026

    Abstract

    Aims Phenylketonuria and type 1 diabetes are lifelong metabolic disorders requiring complex and potentially conflicting nutritional strategies. Their coexistence is rare, yet management may become particularly challenging during transition from pediatric to adult care. We describe the case of a young adult with phenylketonuria who developed type 1 diabetes.

    Methods A 27-year-old man with longstanding phenylketonuria was referred to an adult metabolic-diabetes center after the diagnosis of type 1 diabetes. Clinical, biochemical, nutritional, and continuous glucose monitoring data were reviewed. The intervention included structured therapeutic education, transition from fixed insulin doses to a dynamic regimen based on carbohydrate counting, and revision of medical nutrition therapy using phenylketonuria-adapted low-protein foods and sugar-free phenylalanine-free amino acid supplements.

    Results At diagnosis, HbA1c was 11.5%, with markedly reduced C-peptide levels and high titer anti-GAD antibodies. Ini-tial diabetes management was associated with poor adherence to the phenylketonuria diet, increased intake of conventional protein sources, and elevated phenylalanine levels. After individualized insulin titration and nutritional intervention, HbA1c improved from 11.5% to 7.8%, phenylalanine levels decreased from 842 to 705 μmol/L, insulin requirement declined from 0.55 to 0.3 IU/kg/day, and continuous glucose monitoring showed improved glycemic control without increased hypoglyce-mia. The Glycemia Risk Index improved from high-risk Zone E to low-intermediate-risk Zone B.

    Conclusions This case highlights the need for personalized multidisciplinary care integrating continuous glucose monitor-ing, carbohydrate counting, and phenylketonuria specific nutrition to optimize both metabolic conditions.

    Keywords Phenylketonuria · Type 1 diabetes · CGM · multidisciplinary approach

  • Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems 2026-06-18 00:00

    Nicolò Diego Borella1  · Antonio Ferramosca2  · Giona Castagna1  · Silvia Ippolito1  · Sara Ceresoli2  · Antonio Taverna1  · Beatrice Sonzogni2  · Roberto Trevisan1,3 · Giuseppe Lepore1

    Received: 6 March 2024 / Accepted: 15 October 2024 / Published online: 22 November 2024 © The Author(s) 2024

    Abstract

    Context Advanced hybrid closed loop (AHCL) systems currently represent the most advanced modality of insulin therapy.

    Aim To compare the night-time (from 00 to 07 a.m.) effectiveness in achieving recommended glycemic targets of three dif-ferent AHCL systems in adults with type 1 diabetes (T1D).

    Methods We retrospectively evaluated 55 adults with T1D (mean age 41±16 years, male 40%, diabetes duration 19.4±11.4 years, BMI 24.1±4.1 kg/m2 ) with similar glycemic control (GMI 7.0–7.4%). Twenty-two participants were using the Minimed 780G system, 18 the Tandem t:slim X2 with Control-IQ system and 15 the DBLG1 system. Continuous glucose monitoring derived metrics and insulin requirement of 14 consecutive nights were

    Results All three groups achieved the recommended mean TIR>70%, mean TBR<4%, and mean CV<36% with a similar insulin requirement (Minimed 780G system: TIR 73.9±11.2%, TBR 0.9±1.2%, CV 29±6.7%; Tandem t:slim X2 with Con-trol-IQ system: TIR 74.1±11.1%, TBR 1.1±1.0%, CV 34.5±6.6%; DBLG1 System TIR 71.7±11.3%, TBR 1.4±3.7%, CV 32.4±7.1%). Tight TIR% (70–140 mg/dl) was significantly higher (p<0.01) in the Tandem t:slim X2 with Control-IQ group (51.5±9.8%) when compared to Minimed 780G group (42.1±13.7%) and DBLG1 System (40.1±10.5%). In all three groups the insulin infusion similarly decreased from midnight to 05.00 am and then increased.

    Conclusions All the three AHCL systems achieved the recommended TIR, TBR and CV without difference in insulin requirement. The Tandem Control-IQ system obtained a higher tight TIR.

Popular Tags

  • 糖尿病足
  • 造口
  • 溃疡
  • 动脉性溃疡
  • 静脉性溃疡
  • 放射性溃疡
  • 烧伤
  • 创伤
  • 祛疤止痒
  • 皮肤病

伤口世界平台生态圈,以“关爱人间所有伤口患者”为愿景,连接、整合和拓展线上和线下的管理慢性伤口的资源,倡导远程、就近和居家管理慢性伤口,解决伤口专家的碎片化时间的价值创造、诊疗经验的裂变复制、和患者的就近、居家和低成本管理慢性伤口的问题。

 

消息订阅

关注伤口世界动态,了解专业领域最新科技
Copyright © 2026 中诺医疗. All Rights Reserved
皖ICP备19014494号-1

学术会议

2019广东省医疗行业协会伤口管理分会年会

扫一扫了解详情:

 

  • 2019年6月15日 中国广州
  • 主办单位:广东省医疗行业协会伤口管理分会

伤口世界提示

任何关于疾病的建议都不能替代执业医师的面对面诊断。所有门诊时间仅供参考,最终以医院当日公布为准。

网友、医生言论仅代表其个人观点,不代表本站同意其说法,请谨慎参阅,本站不承担由此引起的法律责任。